RxDoctor Payments Data

Winston Montero, MD

Physical Medicine & Rehabilitation · Oxnard, CANPI 1851550404

Payments from drug & device makers

$993in general payments, 2019–2025

Across 34 payments — averaging $29.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$362
  • Scilex Pharmaceuticals Inc.$161
  • Merz North America, Inc.$139
  • Medtronic$119
  • Lilly USA, LLC$64
  • Pfizer$51
  • plus $98 from 5 others

What the payments were for

  • Food & beverage$993100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$993 in reported general payments places this provider in the 75th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California

Medicare billing

Part B allowed, 2024
$415,316
Medicare patients
341
Services billed
2,861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen627$12,824
ZtlidoLidocaine27$10,629
Lidocaine62$7,528
Diclofenac Sodium73$7,349
Tizanidine Hcl74$6,858
Celecoxib121$3,755
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen150$3,588
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$2,115
Pregabalin91$1,973
Oxycodone Hcl101$1,395
Gabapentin156$1,387
Tramadol Hcl88$1,012
Baclofen19$939
Tramadol Hcl ErTramadol Hcl11$834
Cyclobenzaprine Hcl216$688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$161$10,62927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 830 physical medicine & rehabilitation providers in California.

Other physical medicine & rehabilitation in Oxnard

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →